ClinConnect ClinConnect Logo
Search / Trial NCT03032458

Efficacy of Pethidine, Ketorolac And Xylocaine Gel As Analgesics For Pain Control In Shockwave Lithotripsy

Launched by MANSOURA UNIVERSITY · Jan 25, 2017

Trial Information

Current as of May 30, 2025

Completed

Keywords

Shock Wave Lithotripsy Ketorolac Xylocaine Gel Pethidine

ClinConnect Summary

Pain perception during shockwave lithotripsy (SWL) is affected by patient-related factors like age, gender, and body habitus moreover, young female patients, anxious and depressed patients or thin patients experience more pain during SWL.

Several physical variables influencing treatment-related pain have been identified: the type of the shockwave source, size, and site of stone burden, peak pressure of the shockwaves, diameter of the focal zone, and size of the aperture of the shockwave source reflecting the area of shockwave entry at the skin.

Pain relief during SWL is vital, not only to...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with renal and upper ureteral stones amenable to SWL.
  • Exclusion Criteria:
  • Allergy to pethidine.
  • Allergy to Ketorolac.
  • Allergy to Xylocaine gel.
  • American Society of Anesthesiologists score ≥ 3 (ASA III or more).
  • Pregnancy.
  • Patients with a pacemaker.
  • Bleeding diatheses.
  • Uncontrolled urinary tract infection (UTI).
  • Severe obesity which prevent targeting of the stone.
  • Body Mass IndexBMI (40 or more)
  • Arterial aneurysm in the vicinity of the stone.
  • Anatomical obstruction distal to the stone.

About Mansoura University

Mansoura University is a prestigious academic institution located in Egypt, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, it leverages its extensive resources and expertise in various fields of healthcare to facilitate innovative research initiatives aimed at improving patient outcomes. The university collaborates with a network of healthcare professionals and researchers to conduct high-quality clinical trials, focusing on addressing critical health challenges through rigorous scientific methodologies. Its dedication to ethical research practices and adherence to regulatory standards underscores its role as a leader in the medical research community.

Locations

Mansourah, Aldakahlia, Egypt

Patients applied

0 patients applied

Trial Officials

Hassan Abol-Enein, MD, Phd

Study Chair

Urology and Nephrology Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials